What does the biohacking supplement trend get right, and what does it get wrong?

The trend started when optimization became consumer wellness

The biohacking supplement trend did not begin with one product. It became visible in the early 2020s when three currents merged: wearable tracking, longevity media, and influencer supplement stacks. Bryan Johnson’s Blueprint project, launched in 2021, turned the idea of a measured lifestyle into a public spectacle, with diet, sleep, biomarkers, and a large supplement protocol presented as an anti-aging system.⁶ At the same time, podcasts and creator-led health media made compounds such as creatine, magnesium, ashwagandha, collagen, NMN, and nicotinamide riboside feel like tools for performance rather than ordinary supplements.⁷

The timing matters. By 2024, McKinsey described a $1.8 trillion global wellness market in which consumers were increasingly asking for science-backed and data-driven products rather than vague naturalness.⁸ That is the cultural opening biohacking filled. It gave supplement companies a more serious vocabulary: biomarkers, protocols, mitochondrial support, glucose control, sleep architecture, recovery, healthspan.

Some of that vocabulary reflects real science. Some of it is marketing dressed in lab language.

What culture added: podcasts, stacks, and measurable identity

The trend’s cultural engine is not only celebrity adoption. It is the promise that health can be made visible. A sleep score, continuous glucose monitor graph, VO2 max estimate, blood test, or biological-age report gives the buyer a number to improve. Supplements then become interventions in a feedback loop.

That is why the “stack” became the central format. A stack implies design: one product for sleep, one for focus, one for muscle, one for inflammation, one for longevity. Andrew Huberman’s supplement discussions and AG1 sponsorship ecosystem helped normalize daily protocols for a mass audience, while longevity figures such as Johnson made large stacks part of the spectacle.⁷, ⁹ Industry coverage has also linked podcast amplification to surging interest in NAD precursors and healthy-aging products.¹⁰

The better version of this trend asks, “What problem am I trying to solve, and how will I know if this worked?” The worse version asks, “What are high performers taking?” That second question is where biohacking becomes expensive imitation.

What the evidence actually supports

The trend gets one big thing right: supplements should be judged by outcomes, not vibes. Creatine is the cleanest example. The International Society of Sports Nutrition position stand concluded that creatine monohydrate is effective for increasing high-intensity exercise capacity and lean body mass during training, with a strong safety record in studied populations.3 That fits the biohacking frame because the outcome is measurable: strength, power, training volume, and body composition.

Caffeine is another evidence-aligned “biohack,” although it is usually too familiar to sound futuristic. Its performance effects are acute, dose-sensitive, and constrained by sleep tradeoffs. Vitamin D, iron, B12, iodine, and omega-3s can matter when intake or status is low, but the key word is “when.” Correcting a deficiency is not the same claim as optimizing an already sufficient person.

NAD precursors show the gap between promise and proof. Nicotinamide riboside and nicotinamide mononucleotide are plausible because NAD biology is real and aging is associated with altered cellular metabolism. Human trials show that NAD-boosting compounds can raise NAD-related metabolites, and researchers are testing whether that translates into functional outcomes.⁵ But a biomarker moving in the desired direction does not prove longer life, slower aging, or broad cognitive enhancement. A 2024 randomized trial in peripheral artery disease found that nicotinamide riboside, with or without resveratrol, improved walking-related outcomes in that specific population, which is interesting. It is not evidence that healthy adults should take NAD precursors for longevity.¹¹

The trend gets the hierarchy wrong when it treats mechanistic plausibility as consumer proof. Resveratrol, spermidine, fisetin, senolytic blends, nootropic stacks, greens powders, and “mitochondrial” formulas often rely on a chain of reasoning: mechanism, animal data, small human biomarker study, influencer adoption, subscription product. Each link may be defensible. The full claim often is not.

Regulation is the part biohacking underplays

Biohacking culture loves measurement, but it often underweights product quality. In the United States, dietary supplements do not require FDA approval for safety and effectiveness before marketing in many cases.¹ That does not mean every supplement is unsafe. It means the burden shifts to the buyer: choose reputable brands, look for third-party testing, avoid proprietary blends when doses matter, and be skeptical of disease-adjacent claims.

This is especially important for multi-ingredient stacks. If one ingredient causes insomnia, gastrointestinal symptoms, liver enzyme changes, or interacts with a medication, a 12-product protocol makes the culprit harder to identify. More ingredients can mean less interpretability.

Is the trend durable or peaking?

The word “biohacking” may peak, but the behavior behind it is durable. Wearables, home testing, longevity clinics, GLP-1-era body composition tracking, and consumer demand for clinically supported products are not going away.⁸ What may fade is the maximalist stack: 40 pills, vague longevity claims, and no stop rule.

The likely next phase is narrower and more evidence-filtered. Creatine for training and aging muscle. Protein and essential nutrients for gaps. Magnesium or melatonin used carefully for sleep timing rather than daily sedation. NAD precursors reserved for people who understand that the evidence is still developing. More testing, but also more restraint.

What the reader should actually do

Use the trend’s discipline, not its excess. Start with a target: sleep latency, strength, LDL cholesterol, ferritin, vitamin D status, migraine frequency, training recovery, or another concrete outcome. Pick one supplement with a plausible indication. Use an evidence-based dose. Track for a defined period, usually 4 to 12 weeks depending on the outcome. Stop if nothing changes.

The best biohack is not the biggest stack. It is a clean experiment with a reason to start and a reason to stop.